Intermittent versus continuous clodronate administration in postmenopausal women with low bone mass
- 18 February 2000
- Vol. 26 (3) , 269-274
- https://doi.org/10.1016/s8756-3282(99)00273-2
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Short-Term Intravenous Bisphosphonates in Prevention of Postmenopausal Bone LossJournal of Bone and Mineral Research, 1997
- Cyclical intravenous clodronate in postmenopausal osteoporosis: Results of a long-term Clinical trialBone, 1996
- Theoretical perspective: A new model for the regulation of bone resorption, with particular reference to the effects of bisphosphonatesJournal of Bone and Mineral Research, 1996
- Cyclical clodronate is effective in preventing postmenopausal bone loss: A comparative study with transcutaneous hormone replacement therapyJournal of Bone and Mineral Research, 1995
- Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosisJournal of Bone and Mineral Research, 1994
- The bone-remodeling transient: Implications for the interpretation of clinical studies of bone mass changeJournal of Bone and Mineral Research, 1994
- The effect of short term treatment with alendronate on vertebral density and biochemical markers of bone remodeling in early postmenopausal womenJournal of Clinical Endocrinology & Metabolism, 1993
- Effects of one-year cyclical treatment with clodronate on postmenopausal bone lossBone, 1993
- FOCAL OSTEOMALACIA DUE TO LOW-DOSE DIPHOSPHONATE THERAPY IN PAGET'S DISEASEThe Lancet, 1984
- Effects of disodium dichloromethylene diphosphonate on bone loss in paraplegic patients.Journal of Clinical Investigation, 1981